IAM
GSK icon

Iridian Asset Management’s GSK GSK Stock Holding History

Iridian Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-16,000
Closed -$769K – 78
2015
Q3 		$769K Sell
16,000
-8,000
-33% -$416K 0.01% 59
2015
Q2 		$1.25M Buy
+24,000
New +$1.35M 0.01% 61

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Iridian Asset Management's GSK Position: Q4 2015 in Review

Iridian Asset Management sold out of GSK (GSK) in Q4 2015, closing a stake of 16,000 shares — an estimated $769K sold.

Iridian Asset Management first reported a position in GSK in Q2 2015 and held it in 2 quarters. The position peaked at $1.25M in Q2 2015. 718 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

  • Iridian Asset Management reported no remaining GSK position as of Q4 2015 after selling out during the quarter.
  • Iridian Asset Management sold 16,000 GSK shares in Q4 2015, an estimated $769K.
  • Iridian Asset Management first reported a position in GSK in Q2 2015 and held it in 2 quarters.
  • Iridian Asset Management's GSK position peaked at $1.25M in Q2 2015.
  • 718 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Iridian Asset Management's 13F filing for Q4 2015, filed 5 Feb 2016.